Aernoud Fiolet

194 Chapter 7 OR “major adverse cardiovascular events” OR “cardiovascular events” OR “cardiac events” OR “cardiovascular death” OR “cardiovascular mortality” OR “cardiac death” OR “cardiac mortality” OR “Arteriosclerosis” OR "Atherosclerosis" OR “Cardiovascular Disease” OR CVD OR ASCVD OR “Peripheral Arterial Disease” OR PAD OR “Intermittent Claudication” OR “Fontaine” OR “Brain Ischemia” OR “Brain infarction” OR “Cerebral infarction” OR “Brain Stem infarction” OR “Transient ischemic attack” OR TIA OR “Stroke” OR “Cerebrovascular accident” OR CVA OR “Carotid Stenosis” OR “Carotid Artery Thrombosis”) AND ( colchicine OR colchicin OR colcemid OR demecolcine OR colchamine OR lumicolchicine OR gamma-lumicolchicine OR beta-lumicolchicine OR “aqua colchin” OR colchicum OR colchilyOR colchimedioOR colchiquimOR colchisol OR colchysat OR colcineOR colcrys OR colgout OR goutichine OR goutnil OR kolkicin OR “nsc 757” OR tolchicine OR colchimax)